Skip to main content

Table 1 Baseline characteristics of patients with mixed cell adenocarcinoma

From: Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary

Variable

Classification

Number (n=2,818)

Percentage (100%)

Race

White

2376

84.3

Black

128

4.5

Others

302

10.7

Unknown

12

0.4

Age

18-59

1627

57.7

60-72

789

28

73-96

402

14.3

Size

0-83

668

23.7

84-155

866

30.7

156+

456

16.2

Unknown

828

29.4

Grade

Well differentiated

225

8

Moderately differentiated

461

16.4

Poorly differentiated

1090

38.7

Undifferentiated

623

22.1

Unknown

419

14.9

SEER stage

Localized

551

19.6

Regional

900

31.9

Distant

1342

47.6

Unknown

25

0.9

AJCC stage

Stage I

808

28.7

Stage II

338

12

Stage III

865

30.7

Stage IV

331

11.7

Unknown

476

16.9

Laterality

Left

874

31

Right

869

30.8

One side, NOS

7

0.2

Bilateral, single primary

1002

35.6

Paired site

66

2.3

Surgery

None

57

2

Tumor removal

486

17.2

Tumor removal with omentectomy

1056

37.5

Cytoreductive surgery

1124

39.9

Pelvic exenteration

40

1.4

Unknown

55

2